Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net earnings	$ 115,620	$ 94,892
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	33,969	37,077
Stock compensation expense	14,298	12,787
Deferred income taxes	(273)	(1,918)
Provision for credit losses	(118)	238
Unrealized gain on foreign currency transactions and deferred compensation	(1,207)	(730)
(Gain) loss on disposal of assets and asset impairment	(94)	1,479
Change in fair value of contingent consideration liability	0	(91)
Changes in assets and liabilities
Accounts receivable	(8,900)	5,220
Inventories	2,622	(8,738)
Prepaid expenses and other current assets	24	1,199
Accounts payable and accrued expenses	(9,024)	(9,734)
Income taxes	1,440	(3,110)
Other	924	1,111
Net cash provided by operating activities	149,281	129,682
Cash flows from investing activities:
Capital expenditures and intangible assets acquired	(27,275)	(22,936)
Cash paid for acquisitions, net of cash acquired	(323)	0
Proceeds from sale of assets	267	272
Investment in affiliates	(144)	(113)
Net cash used in investing activities	(27,475)	(22,777)
Cash flows from financing activities:
Proceeds from revolving loan	70,000	26,000
Principal payments on revolving loan	(106,000)	(108,569)
Principal payments on finance leases	(145)	(169)
Proceeds from stock options exercised	6,867	15,084
Dividends paid	(28,276)	(25,572)
Repurchases of common stock	(54,008)	(5,376)
Net cash used in financing activities	(111,562)	(98,602)
Effect of exchange rate changes on cash	5,334	944
Increase in cash and cash equivalents	15,578	9,247
Cash and cash equivalents beginning of period	49,515	64,447
Cash and cash equivalents end of period	$ 65,093	$ 73,694